Go to Page # Page of 30

Reimagining Medicine By Vas Narasimhan

 Vas Narasimhan
Description: Focusing on a medicines company, driving growth with a leading pipeline & cutting-edge platforms, building a new culture & focus on impact for society as a reimagination of medicine.
Views: 1226
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: Novartis AG
 ‐ More of their Presentations
Novartis AG

Reimagining Medicine
Vas Narasimhan, CEO
January 7, 2019

This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be identified by
words such as “potential,” “expected,” “will,” “planned,” “pipeline,” “ ... See more

Recent Presentations

Yalin Firinci
19 August, 2019

Regulatory Science for R&D Promotion

At present, the nation’s policy for Research and Development (R&D) promotion of innovative pharmaceuticals & improvement of environments for the R&D is formulated by Japanese gover

18 August, 2019
16 August, 2019